| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 07/15/1999 | WO1999035261A1 Novel gene having reverse transcriptase motif |
| 07/15/1999 | WO1999035260A1 Non-identical genes and their application in improved molec ular adjuvants |
| 07/15/1999 | WO1999035259A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | WO1999035257A1 Target for treating atherosclerosis, obesity and type ii diabetes |
| 07/15/1999 | WO1999035256A1 Screening interactor molecules with whole genome oligonucleotide or polynucleotide arrays |
| 07/15/1999 | WO1999035254A1 Use of topoisomerase to enhance rt-based molecular biology techniques and rt-based gene delivery |
| 07/15/1999 | WO1999035253A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035252A2 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035246A1 Novel steroid-activated nuclear receptors and uses therefor |
| 07/15/1999 | WO1999035243A2 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | WO1999035241A1 Transgenic rabbit that expresses a functional human lipoprotein (a) |
| 07/15/1999 | WO1999035168A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035165A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | WO1999035160A1 Human fk506 binding proteins |
| 07/15/1999 | WO1999035158A1 36 human secreted proteins |
| 07/15/1999 | WO1999035106A2 Mammalian edg-7 receptor homologs |
| 07/15/1999 | WO1999034908A1 Method and articles for transfection of genetic material |
| 07/15/1999 | WO1999034837A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | WO1999034836A1 Methods of controlling cell differentiation and growth using a fusion protein and a drug |
| 07/15/1999 | WO1999034827A1 Activated t-cells and their uses |
| 07/15/1999 | WO1999034823A2 METHODS FOR PREVENTING AND TREATING FIBROTIC DISEASES RESULTING FROM ACCUMULATION OF EXCESS EXTRACELLULAR MATRIX INDUCED BY TGFβ USING RENIN INHIBITORS |
| 07/15/1999 | WO1999034819A2 Use of citrulline peptides derived from filaggrin for treating autoimmune diseases |
| 07/15/1999 | WO1999034817A1 Agent for treating allergic or hypersensitivity condition |
| 07/15/1999 | WO1999034816A1 Method for administering monomeric insulin analogs |
| 07/15/1999 | WO1999034815A1 Method for administering aspb28-human insulin |
| 07/15/1999 | WO1999034687A1 Animal nutrition compositions |
| 07/15/1999 | WO1999034670A1 Gene mutant animals |
| 07/15/1999 | WO1999034669A1 Cloning using donor nuclei from differentiated fetal and adult cells |
| 07/15/1999 | WO1999034663A1 Methods for plant transformation and regeneration |
| 07/15/1999 | WO1999028836A3 Arrangement and method for the analysis of nucleotide sequences |
| 07/15/1999 | WO1999028466A8 Compositions and methods of use of het |
| 07/15/1999 | WO1999026070A3 Method for automatic implementation of chemical or biological methods |
| 07/15/1999 | WO1999025857A3 Transgenic models of inflammatory disease |
| 07/15/1999 | WO1999025837A3 Method for producing virus-like particles on the basis of polyoma viruses |
| 07/15/1999 | WO1999025823A3 Recombinant allergen with reduced enzymatic activity |
| 07/15/1999 | WO1999025734A3 Th2 CELL DEPLETION; COMPOSITIONS; METHODS |
| 07/15/1999 | WO1999024612A3 Multiple sequential polynucleotide displacement reactions for signal amplification and processing |
| 07/15/1999 | WO1999024573A3 SOYBEAN HOMOLOG OF SEED-SPECIFIC TRANSCRIPTION ACTIVATOR FROM $i(PHASEOLUS VULGARIS) |
| 07/15/1999 | WO1999024561A3 Genetic engineering of lignin biosynthesis in plants |
| 07/15/1999 | WO1999024466A3 Multi-mer peptides derived from hepatitis c virus envelope proteins for diagnostic use and vaccination purposes |
| 07/15/1999 | WO1999023867A3 Bmog, a protein member of the myelin-oligodendrocyte glycoprotein family and its use |
| 07/15/1999 | WO1999023232B1 Glyphosate resistant transgenic plants |
| 07/15/1999 | WO1999021992A9 Nucleic acid molecules encoding a glutamate receptor |
| 07/15/1999 | WO1999019363B1 Monoclonal antibody to alpha2-macroglobulin and its use for detecting glucan |
| 07/15/1999 | WO1999018990A9 The il-1 receptor related protein 3 (il-1rrp3) |
| 07/15/1999 | WO1999018216A9 Chimeric vaccine against tick-borne encephalitis virus |
| 07/15/1999 | WO1999016298A9 Nepovirus resistance in grapevine |
| 07/15/1999 | WO1999013095A9 Use of multivalent chimeric peptide-loaded, mhc/ig molecules to detect, activate or suppress antigen-specific t cell-dependent immune responses |
| 07/15/1999 | WO1998053066A9 Smad2 phosphorylation and interaction with smad4 |
| 07/15/1999 | WO1998042855A9 Rapid production of autologous tumor vaccines by using hsv amplicon vectors |
| 07/15/1999 | DE19801154A1 Preparation of pure recombinant thyroid stimulating hormone receptor useful for detection of autoantibodies in human serum |
| 07/15/1999 | DE19801153A1 Selection of a ribozymes useful for, e.g. inhibiting gene expression and improving nuclease resistance |
| 07/15/1999 | DE19800746A1 Bacterial plasmid vectors for cloning foreign DNA, analysis of transcription signals, and expression of fusion proteins, etc |
| 07/15/1999 | DE19800363A1 New inhibitors of serine protease useful for treating inflammation |
| 07/15/1999 | CA2325049A1 Mammalian edg-7 receptor homologs |
| 07/15/1999 | CA2324972A1 Identification of lysolipid receptors involved in inflammatory response |
| 07/15/1999 | CA2318521A1 Method for controlling the division and/or elongation of eukariotic cells |
| 07/15/1999 | CA2318435A1 Human fk506 binding proteins |
| 07/15/1999 | CA2318380A1 Compositions and methods for treating cells having double minute dna |
| 07/15/1999 | CA2318369A1 Recombinant, active caspases and uses thereof |
| 07/15/1999 | CA2317940A1 Assay for predicting the angiographic response to lipid-lowering therapy in patients |
| 07/15/1999 | CA2317918A1 Il-1 delta dna and polypeptides |
| 07/15/1999 | CA2317898A1 Human vps35/mem3-related protein |
| 07/15/1999 | CA2317817A1 Il-17rh dna and polypeptides |
| 07/15/1999 | CA2317809A1 Gene mutant animals |
| 07/15/1999 | CA2317739A1 Method for administering aspb28-human insulin |
| 07/15/1999 | CA2317733A1 Method for administering monomeric insulin analogs |
| 07/15/1999 | CA2317702A1 36 human secreted proteins |
| 07/15/1999 | CA2317696A1 Mammalian matrix-type metalloprotease |
| 07/15/1999 | CA2317695A1 Solid phase selection of differentially expressed genes |
| 07/15/1999 | CA2317666A1 Method and articles for transfection of genetic material |
| 07/15/1999 | CA2317508A1 Methods for plant transformation and regeneration |
| 07/15/1999 | CA2317494A1 Cloning using donor nuclei from differentiated fetal and adult cells |
| 07/15/1999 | CA2317463A1 Screening method for apoptosis and necrosis |
| 07/15/1999 | CA2317382A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2317109A1 The process for expression and production of recombinant protein gp90 derived from glicoprotein envelop of equine infectious anemia virus eiav |
| 07/15/1999 | CA2317057A1 Apoptosis inducing molecule ii |
| 07/15/1999 | CA2317020A1 Non-identical genes and their application in improved molecular adjuvan ts |
| 07/15/1999 | CA2316973A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316864A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2316775A1 Secreted proteins and polynucleotides encoding them |
| 07/15/1999 | CA2315880A1 Streptococcal heat shock proteins of the hsp60 family |
| 07/15/1999 | CA2315708A1 Stabilization of lipid:dna formulations during nebulization |
| 07/15/1999 | CA2315265A1 Extension of cellular lifespan, methods and reagents |
| 07/15/1999 | CA2312848A1 Polymeric arrays and methods for their use in binding assays |
| 07/15/1999 | CA2312173A1 Method comprising capture molecule fixed on disc surface |
| 07/15/1999 | CA2283494A1 Recombinant p37/flaa as a diagnostic reagent |
| 07/15/1999 | CA2245909A1 Novel compounds |
| 07/14/1999 | EP0928968A1 Screening method for apoptosis and necrosis |
| 07/14/1999 | EP0928831A1 Cholera organisms, vaccines and preparation thereof |
| 07/14/1999 | EP0928419A1 Compositions and methods for modulating type i interleukin-1 receptor expression |
| 07/14/1999 | EP0928342A1 The use of modular oligonucleotides as probes or primers in nucleic acid based assay |
| 07/14/1999 | EP0928339A1 Mammalian artificial chromosomes |
| 07/14/1999 | EP0928338A1 Process for producing plants with female sterility |
| 07/14/1999 | EP0928337A1 A human protein tyrosine kinase |
| 07/14/1999 | EP0928336A1 Chaperone fragments |
| 07/14/1999 | EP0928335A2 METHOD FOR USING OLIGONUCLEOTIDES HAVING MODIFIED CpG DINUCLEOSIDES |
| 07/14/1999 | EP0928334A1 Methods for preparing synthetic repetitive dna |
| 07/14/1999 | EP0928332A1 Process for developing mammals with definite genetic features |
| 07/14/1999 | EP0928331A1 Biologically active fragment of bacillus stearothermophilus dna polymerase |